<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>PE468538</GBSeq_locus>
    <GBSeq_length>939</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>15-FEB-2024</GBSeq_update-date>
    <GBSeq_create-date>15-FEB-2024</GBSeq_create-date>
    <GBSeq_definition>KR 1020230093241-A/59: COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA DEFICIENCY</GBSeq_definition>
    <GBSeq_primary-accession>PE468538</GBSeq_primary-accession>
    <GBSeq_accession-version>PE468538.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|PE468538.1|</GBSeqid>
      <GBSeqid>pat|KR|1020230093241|59</GBSeqid>
      <GBSeqid>gi|2677189695</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020230093241-A/59</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Adeno-associated virus - 4</GBSeq_source>
    <GBSeq_organism>Adeno-associated virus - 4</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Quintoviricetes; Piccovirales; Parvoviridae; Parvovirinae; Dependoparvovirus; Dependoparvovirus primate1</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..939</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Murlidharan,G.</GBAuthor>
          <GBAuthor>Brown,J.</GBAuthor>
          <GBAuthor>Knoll,E.</GBAuthor>
          <GBAuthor>Shu,Y.</GBAuthor>
          <GBAuthor>Bales,K.</GBAuthor>
          <GBAuthor>Hou,J.</GBAuthor>
          <GBAuthor>Adeluyi,A.</GBAuthor>
          <GBAuthor>Hoffman,B.</GBAuthor>
          <GBAuthor>Jagtap,S.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA DEFICIENCY</GBReference_title>
        <GBReference_journal>KR1020230093241-A 59 27-JUN-2023 VOYAGER THERAPEUTICS, INC</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020237006825-A/59~AN KR 1020237006825~AD 2023-03-23~PN KR 1020230093241~PD 2023-06-27~AT COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL~AT DISORDERS RELATED TO GLUCOSYLCERAMIDASE BETA DEFICIENCY~AI Murlidharan, Giridhar|Brown, Jeffrey|Knoll, elisabeth|Shu,~AI Yanqun|Bales, Kelly|Hou, Jinzhao|Adeluyi, Adewale|Hoffman,~AI Brett|Jagtap, Smita~AA VOYAGER THERAPEUTICS, INC.~PR US 63/057,265=2020-07-27~OS Adeno-associated virus 4~TY DNA~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..939</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>939</GBInterval_to>
            <GBInterval_accession>PE468538.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Adeno-associated virus - 4</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:57579</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>atggagctggtcgggtggctggtggaccgcgggatcacgtcagaaaagcaatggatccaggaggaccaggcgtcctacatctccttcaacgccgcctccaactcgcggtcacaaatcaaggccgcgctggacaatgcctccaaaatcatgagcctgacaaagacggctccggactacctggtgggccagaacccgccggaggacatttccagcaaccgcatctaccgaatcctcgagatgaacgggtacgatccgcagtacgcggcctccgtcttcctgggctgggcgcaaaagaagttcgggaagaggaacaccatctggctctttgggccggccacgacgggtaaaaccaacatcgcggaagccatcgcccacgccgtgcccttctacggctgcgtgaactggaccaatgagaactttccgttcaacgattgcgtcgacaagatggtgatctggtgggaggagggcaagatgacggccaaggtcgtagagagcgccaaggccatcctgggcggaagcaaggtgcgcgtggaccaaaagtgcaagtcatcggcccagatcgacccaactcccgtgatcgtcacctccaacaccaacatgtgcgcggtcatcgacggaaactcgaccaccttcgagcaccaacaaccactccaggaccggatgttcaagttcgagctcaccaagcgcctggagcacgactttggcaaggtcaccaagcaggaagtcaaagactttttccggtgggcgtcagatcacgtgaccgaggtgactcacgagttttacgtcagaaagggtggagctagaaagaggcccgcccccaatgacgcagatataagtgagcccaagcgggcctgtccgtcagttgcgcagccatcgacgtcagacgcggaagctccggtggactacgcggacagattggctagaggacaacctctctga</GBSeq_sequence>
  </GBSeq>
